Lizanne Falsetto

DR. SEAN KHOZIN JOINS BRAVEN AS A SENIOR LIFE SCIENCES & HEALTHCARE PARTNER

Retrieved on: 
Monday, May 8, 2023
Telehealth, LLP, SKMD, Health, Data science, Information exchange, BlackRock, Cravath, Swaine & Moore, Biomedical Research, National Cancer Institute, Data, Partner (business rank), Associate, Lizanne Falsetto, Food and Drug Administration Amendments Act of 2007, Investment, Royal Army Medical Corps, Drug discovery, Artificial intelligence, Johnson & Johnson, FDA, Frazier Healthcare Partners, Complementary and Natural Healthcare Council, Food, Massachusetts Institute of Technology, Management, Pharmaceutical industry, Nursing, Braven, Cancer

NEW YORK, May 8, 2023 /PRNewswire/ -- Braven, an early-stage investor that co-builds breakthroughs in large, regulated sectors – finance, healthcare, and industrials – announces the appointment of Dr. Sean Khozin as a Senior Life Sciences and Healthcare Partner. Dr. Khozin brings industry-leading experience with data science innovation in healthcare, pioneered over the course of his career as a physician, researcher, founder, corporate executive & public servant.

Key Points: 
  • As a pioneer in life science development and data science, Dr. Khozin joins Braven's leadership team to co-build and invest in system innovations within the healthcare sector.
  • NEW YORK, May 8, 2023 /PRNewswire/ -- Braven, an early-stage investor that co-builds breakthroughs in large, regulated sectors – finance, healthcare, and industrials – announces the appointment of Dr. Sean Khozin as a Senior Life Sciences and Healthcare Partner.
  • Dr. Khozin brings industry-leading experience with data science innovation in healthcare, pioneered over the course of his career as a physician, researcher, founder, corporate executive & public servant.
  • "Braven has built exactly what we need in healthcare and the life sciences right now," said Dr. Khozin.

LIZANN EISEN JOINS BRAVEN AS SENIOR REGULATORY AND STRATEGIC PARTNER

Retrieved on: 
Tuesday, January 24, 2023
University, Disclosure, LLP, Security (finance), Risk assessment, Partner (business rank), Cravath, Swaine & Moore, Crawford and Co Building, Corporate finance, VC, Lizanne Falsetto, Cornell University, Cravath, Acquisition, Division, Management, Bank, Braven

NEW YORK, Jan. 24, 2023 /PRNewswire/ -- Braven, a venture capital firm pioneering a new operating model to co-build  breakthrough early-stage startups, announces the appointment of LizAnn Eisen as a Senior Regulatory and Strategic Partner. Eisen brings a wealth of experience and relationships in commercial, legal, and regulatory matters that will add substantial value to Braven's unique co-building model and its portfolio companies.

Key Points: 
  • As a leader in corporate regulation and capital markets, Eisen will hold a key senior role within the firm's unique venture model to co-build companies transforming regulated industries
    NEW YORK, Jan. 24, 2023 /PRNewswire/ -- Braven, a venture capital firm pioneering a new operating model to co-build  breakthrough early-stage startups, announces the appointment of LizAnn Eisen as a Senior Regulatory and Strategic Partner.
  • Eisen brings a wealth of experience and relationships in commercial, legal, and regulatory matters that will add substantial value to Braven's unique co-building model and its portfolio companies.
  • Braven, a VC firm focused on regulated industries, appoints LizAnn Eisen as a Senior Regulatory and Strategic Partner
    Prior to joining Braven, Eisen most recently served at the Securities and Exchange Commission as Deputy Director, Disclosure Program, for the Division of Corporation Finance.
  • A joint venture with Josh Harris's 26North, Braven is an institutionally backed, early-stage venture firm pioneering the model for system innovations in regulated industries.

LizAnn Eisen Joins Division of Corporation Finance as Deputy Director, Disclosure Program

Retrieved on: 
Thursday, January 27, 2022
Disclosure, Corporation, Division, LLP, Review, Securities Exchange Act of 1934, SEC, Lizanne Falsetto, Trinidad and Tobago Securities and Exchange Commission, Cravath, Securities Act of 1933, University, Private practice, Cravath, Swaine & Moore, Security (finance), Decision-making, Cornell University, Corporate finance, Financial adviser

Washington, D.C.--(Newsfile Corp. - January 27, 2022) - The Securities and Exchange Commission today announced that LizAnn Eisen has been named Deputy Director, Disclosure Program, for the Division of Corporation Finance.In this role, she will ensure the effectiveness of the division's review of company filings, monitor market trends, and assess emerging risks.

Key Points: 
  • Washington, D.C.--(Newsfile Corp. - January 27, 2022) - The Securities and Exchange Commission today announced that LizAnn Eisen has been named Deputy Director, Disclosure Program, for the Division of Corporation Finance.In this role, she will ensure the effectiveness of the division's review of company filings, monitor market trends, and assess emerging risks.
  • Prior to joining the SEC, LizAnn was an adjunct professor and senior lecturer at Cornell Tech/Cornell Law School and an adjunct professor at the University of Oregon law school.
  • "I'm delighted to welcome LizAnn to the division as Deputy Director for Disclosure Operations," said Division of Corporation Finance Director Renee Jones.
  • "I am excited to join the Division of Corporation Finance and work together with the talented and dedicated division staff to make sure companies live up to the full disclosure mandate on which investor confidence depends," said Ms. Eisen.